The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Canopy Healthcare Group
Stock and Other Ownership Interests - Canopy Healthcare Group
Consulting or Advisory Role - MSD
Subcutaneous nivolumab versus intravenous nivolumab in patients with previously treated, advanced, or metastatic clear cell renal cell carcinoma.
 
Matias Rodrigo Chacon
No Relationships to Disclose
 
Hernan J. Cutuli
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; MSD Oncology
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; MSD Oncology; Pfizer
Research Funding - Bayer; Bristol-Myers Squibb; Janssen; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen; MSD
 
Sergio Bracarda
Travel, Accommodations, Expenses - Astellas Pharma
 
Marco Maruzzo
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Merck Serono; MSD; Pfizer
 
Maria Teresa Bourlon
Leadership - BMS
Honoraria - BMS; Tecnofarma; Tecnofarma
Consulting or Advisory Role - Asofarma; Bayer; Bristol-Myers Squibb; Eisai; Ferring; Janssen Oncology; MSD Oncology; Novartis
Speakers' Bureau - Asofarma; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ferring; Ipsen; Janssen Oncology; Medicamenta; Merck; MSD Oncology; Pfizer; Tecnofarma
Expert Testimony - Asofarma
Travel, Accommodations, Expenses - Asofarma; Bristol-Myers Squibb (Mexico); Janssen-Cilag; MSD Oncology; Pfizer
Other Relationship - Sanofi
 
Carmel Jacobs
No Relationships to Disclose
 
Begoña Pérez-Valderrama
Honoraria - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Novartis; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; EUSA Pharma; Ipsen; MSD Oncology; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Ipsen; MSD Oncology; Pfizer; Roche
 
Ignacio Magri
Honoraria - Bristol-Myers Squibb; IQVIA; Syneos Health
Consulting or Advisory Role - Pfizer; Takeda
Research Funding - Bristol-Myers Squibb; IQVIA; Syneos Health
 
Martin Richardet
No Relationships to Disclose
 
Piotr Centkowski
No Relationships to Disclose
 
Simon Yuen Fai Fu
No Relationships to Disclose
 
Pablo Gurman
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Srivani Konduri
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Zhuoxin Yu
Employment - Bristol Myers Squibb Foundation
Stock and Other Ownership Interests - Lilly
 
Heather Vezina
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Heather Vezina
 
Saby George
Consulting or Advisory Role - AVEO; Bayer; Bristol-Myers Squibb; Corvus Pharmaceuticals; Eisai; EMD Serono; Exelixis; Merck; Pfizer; QED Therapeutics; Sanofi; Seattle Genetics/Astellas
Research Funding - Agensys (Inst); Aravive (Inst); Aveo (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Corvus Pharmaceuticals (Inst); Eisai (Inst); Exelixis (Inst); Gilead Sciences (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst); Surface Oncology (Inst)
 
Laurence Albiges
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bellerophon Theraeutics (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Eisai (Inst); Ipsen (Inst); Janssen (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - BMS; MSD